Particularly, the beneficial effects on a broad variety of cell types, including anti-inflammatory effects on astrocytes, microglia, but also myeloid cells, in combination with the trophic effects on oligodendrocytes and neurons, make astrocyte-derived HB-EGF a candidate therapeutic target for a variety of neurological diseases. This evidence concerns the gene HBEGF and nervous system disorder.